Literature DB >> 21150297

Calcium channel functions in pain processing.

John Park1, Z David Luo.   

Abstract

Voltage-gated calcium channels (VGCC) play obligatory physiological roles, including modulation of neuronal: functions, synaptic plasticity, neurotransmitter release and gene transcription. Dysregulation and maladaptive changes in VGCC expression and activities may occur in the sensory pathway under various pathological conditions that could contribute to the development of pain. In this review, we summarized the most recent findings on the regulation of VGCC expression and physiological functions in the sensory pathway, and in dysregulation and maladaptive changes of VGCC under pain-inducing conditions. The implications of: these changes in understanding the mechanisms of pain transduction and in new drug design are also discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150297      PMCID: PMC3052250          DOI: 10.4161/chan.4.6.12869

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  137 in total

Review 1.  Localization of voltage-gated ion channels in mammalian brain.

Authors:  James S Trimmer; Kenneth J Rhodes
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

Review 2.  Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke.

Authors:  Takashi Yamamoto; Akira Takahara
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 3.  Regulation of T-type calcium channels: signalling pathways and functional implications.

Authors:  Sylvaine Huc; Arnaud Monteil; Isabelle Bidaud; Guillaume Barbara; Jean Chemin; Philippe Lory
Journal:  Biochim Biophys Acta       Date:  2008-11-24

Review 4.  Calcium channel diversity: multiple roles of calcium channel subunits.

Authors:  Annette C Dolphin
Journal:  Curr Opin Neurobiol       Date:  2009-06-24       Impact factor: 6.627

5.  Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.

Authors:  Cagla Eroglu; Nicola J Allen; Michael W Susman; Nancy A O'Rourke; Chan Young Park; Engin Ozkan; Chandrani Chakraborty; Sara B Mulinyawe; Douglas S Annis; Andrew D Huberman; Eric M Green; Jack Lawler; Ricardo Dolmetsch; K Christopher Garcia; Stephen J Smith; Z David Luo; Arnon Rosenthal; Deane F Mosher; Ben A Barres
Journal:  Cell       Date:  2009-10-08       Impact factor: 41.582

Review 6.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

7.  In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy.

Authors:  Richard B Messinger; Ajit K Naik; Miljen M Jagodic; Michael T Nelson; Woo Yong Lee; Won Joo Choe; Peihan Orestes; Janelle R Latham; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Pain       Date:  2009-07-03       Impact factor: 6.961

8.  Hypoalgesic behaviors of P/Q-type voltage-gated Ca2+ channel mutant mouse, rolling mouse Nagoya.

Authors:  N Fukumoto; Y Obama; N Kitamura; K Niimi; E Takahashi; C Itakura; I Shibuya
Journal:  Neuroscience       Date:  2009-02-25       Impact factor: 3.590

9.  The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin.

Authors:  Claudia S Bauer; Manuela Nieto-Rostro; Wahida Rahman; Alexandra Tran-Van-Minh; Laurent Ferron; Leon Douglas; Ivan Kadurin; Yorain Sri Ranjan; Laura Fernandez-Alacid; Neil S Millar; Anthony H Dickenson; Rafael Lujan; Annette C Dolphin
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  Presynaptic CaV2 calcium channel traffic requires CALF-1 and the alpha(2)delta subunit UNC-36.

Authors:  Yasunori Saheki; Cornelia I Bargmann
Journal:  Nat Neurosci       Date:  2009-08-30       Impact factor: 24.884

View more
  49 in total

Review 1.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception.

Authors:  E Chang; X Chen; M Kim; N Gong; S Bhatia; Z D Luo
Journal:  Eur J Pain       Date:  2014-08-27       Impact factor: 3.931

3.  Transcriptional profiling of intramembranous and endochondral ossification after fracture in mice.

Authors:  Brandon A Coates; Jennifer A McKenzie; Evan G Buettmann; Xiaochen Liu; Paul M Gontarz; Bo Zhang; Matthew J Silva
Journal:  Bone       Date:  2019-07-29       Impact factor: 4.398

Review 4.  Signaling complexes of voltage-gated calcium channels.

Authors:  Ray W Turner; Dustin Anderson; Gerald W Zamponi
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

Review 5.  Modulation of nociceptive ion channels and receptors via protein-protein interactions: implications for pain relief.

Authors:  Tom Rouwette; Luca Avenali; Julia Sondermann; Pratibha Narayanan; David Gomez-Varela; Manuela Schmidt
Journal:  Channels (Austin)       Date:  2015-06-03       Impact factor: 2.581

6.  Four novel interaction partners demonstrate diverse modulatory effects on voltage-gated CaV2.2 Ca2+ channels.

Authors:  Robert Mallmann; Katarina Ondacova; Lucia Moravcikova; Bohumila Jurkovicova-Tarabova; Michaela Pavlovicova; Roman Moravcik; Lucia Lichvarova; Viera Kominkova; Norbert Klugbauer; Lubica Lacinova
Journal:  Pflugers Arch       Date:  2019-01-05       Impact factor: 3.657

7.  Regulation of voltage-gated Ca(2+) currents by Ca(2+)/calmodulin-dependent protein kinase II in resting sensory neurons.

Authors:  Sandra Kostic; Bin Pan; Yuan Guo; Hongwei Yu; Damir Sapunar; Wai-Meng Kwok; Andy Hudmon; Hsiang-En Wu; Quinn H Hogan
Journal:  Mol Cell Neurosci       Date:  2014-07-24       Impact factor: 4.314

8.  AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain.

Authors:  Hongwei Yu; Seung Min Shin; Hongfei Xiang; Dongman Chao; Yongsong Cai; Hao Xu; Rajesh Khanna; Bin Pan; Quinn H Hogan
Journal:  Gene Ther       Date:  2019-05-22       Impact factor: 5.250

Review 9.  Mirogabalin: First Global Approval.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

10.  Peripheral straightjacket (α2δ Ca2+ channel subunit) expression is required for neuropathic sensitization in Drosophila.

Authors:  Thang M Khuong; Zina Hamoudi; John Manion; Lipin Loo; Arjun Muralidharan; G Gregory Neely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.